DOBI Medical Systems

1200 MacArthur Blvd.
Mahwah, New Jersey 07430
Voice: (201) 760 6464
Fax: (201) 760 8860
e-mail: info@DOBIMedical.com

 

TRW Healthcare Solutions and DOBI Medical Systems Announce Joint Medical Software Development Effort 

Reston, VA, June 29, 2000 --- TRW Inc. (NYSE:TRW) and privately held DOBI Medical Systems, LLC (“DOBI Medical”) announced today that they will be jointly developing sophisticated computer-aided diagnostic (“CAD”) software to further enhance DOBI Medical’s innovative Dynamic Optical Breast Imaging (DOBI) System.  Currently designated as an investigational device, the DOBI System is designed to be utilized as an adjunct to mammography for accurate, non-invasive breast cancer diagnosis.

TRW’s Healthcare Solutions operating unit, The Center for Medical Image Analysis has extensive experience in CAD technologies applied to breast cancer detection and differential diagnosis and has applied its expertise to products for a number of other companies in the medical imaging field.  Under the terms of the contract, TRW will apply their CAD technologies expertise to augment the performance of DOBI Medical’s Dynamic Optical Breast Imaging System.  The agreement will also take advantage of TRW’s world-class systems integration experience. 

John Cook, Vice President of TRW Healthcare Solutions, commented on the announcement, “We are impressed with the technical approach DOBI Medical has taken toward breast cancer imaging and feel the combination of our expertise with DOBI’s accomplishments will produce a very sophisticated and useful product for physicians worldwide.

Phillip C. Thomas, President and CEO of DOBI Medical Systems said, “We’re very pleased to be adding TRW’s advanced image analysis technologies to further improve the performance of our breast cancer diagnostic system.  TRW is highly regarded worldwide for its imaging expertise and we are proud to have them as part of our multi-national development team.

According to Dr. Lim Cheung, Vice President of Engineering at DOBI Medical and former Vice President of R&D at TREX Medical, “We believe the addition of the CAD software from TRW’s Center for Medical Image Analysis, which is based on proven statistical techniques, will enhance the utility and consistency of the DOBI System as an effective diagnostic tool in the medical imaging marketplace.”

TRW’s Center for Medical Image Analysis is considered by many medical imaging professionals and radiologists to be one of the premier computer-aided diagnosis software development companies in the world.  It is the only private company listed in Who’s Who in Computer-Aided Diagnosis by Medical Imaging magazine.

TRW provides advanced technology products and services for automotive, aerospace and information technologies markets worldwide.  A Fortune 500 company, TRW’s 1999 sales were more than $19 billion.

DOBI Medical Systems is an early stage technology development company with corporate headquarters outside New York City in Mahwah, New Jersey.

The DOBI System is designated an investigational device at this time and may only be used for educational and research purposes in the U.S. pending FDA approval.  Use abroad is also subject to the regulations of the respective country. Except for historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risks and uncertainties.  The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  In addition to the factors set forth above, other important factors that could cause actual results to differ materially include, but are not limited to, technical risks associated with new technology development, government regulatory approval, market acceptance of our product, competition and technological change. 

For further information, please contact: Phillip C. Thomas, Chief Executive Officer, 201-760-6464, pct@igaot.pt, or Shellie M. Roth, Investor Relations Partners, Inc., 973-535-8389, roth@irpartners.com.

 

~ We're Changing The Way People See Breast Cancer ~